Disease-modifying agents in osteoarthritis: where are we now and what does the future hold?

Abstract

Cite this article: Bone Joint Res 2023;12(10):654–656.

Keywords

• osteoarthritis
• disease-modifying agents
• osteoarthritis (oa)
• inflammation
• chondrocytes
• randomized controlled trial
• bone remodelling
• knee
• tumour necrosis factor alpha
• intra-articular injection
• cartilage degradation
• mouse model